Civic Intelligence

Eye Samaritans International

990 • Fiscal year 2020 • EIN 46-1046320

Jan 01, 2020 to Dec 31, 2020

Shreveport, LA
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

55th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2020 filings • 501(c)3 • <$500k nonprofits • Source year 2020

Liabilities / Revenue

55th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2020 filings • 501(c)3 • <$500k nonprofits • Source year 2020

Net Margin

56th percentile

9.3%

Higher net margin than 56% of similar nonprofits.

2020 filings • 501(c)3 • <$500k nonprofits • Source year 2020

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2020

Asset Growth

77th percentile

42%

Faster asset growth than 77% of similar nonprofits.

2020 filings • 501(c)3 • <$500k nonprofits • Annualized from 2019 to 2020

Revenue Growth

98th percentile

385%

Faster revenue growth than 98% of similar nonprofits.

2020 filings • 501(c)3 • <$500k nonprofits • Annualized from 2019 to 2020

Assets

Up

$88,856

Up $26,478 (+42%) from 2019

Net Assets

Up

$88,856

Up $26,478 (+42%) from 2019

Liabilities

Flat

$0

Flat from 2019

Revenue

Up

$284,237

Up $225,637 (+385%) from 2019

Expenses

Up

$257,759

Up $121,637 (+89%) from 2019

Net Income

Up

$26,478

Up $104,000 (+134%) from 2019

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$150K$100K$50K$0Assets 2018: $139,900Liabilities 2018: $02018Assets 2019: $62,378Liabilities 2019: $0Net Assets 2019: $62,3782019Assets 2020: $88,856Liabilities 2020: $0Net Assets 2020: $88,8562020Assets 2021: $121,641Liabilities 2021: $2,207Net Assets 2021: $119,4342021Assets 2022: $103,294Net Assets 2022: $103,2942022Assets 2023: $68,920Net Assets 2023: $68,9202023Assets 2024: $55,672Liabilities 2024: $55,672Net Assets 2024: $55,6722024

Highlighted filing

2020

Assets$88,856
Liabilities$0
Net Assets$88,856

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$300K$200K$100K$0-$100KRevenue 2018: $167,375Expenses 2018: $65,059Net Income 2018: $102,3162018Revenue 2019: $58,600Expenses 2019: $136,122Net Income 2019: -$77,5222019Revenue 2020: $284,237Expenses 2020: $257,759Net Income 2020: $26,4782020Revenue 2021: $142,101Expenses 2021: $111,523Net Income 2021: $30,5782021Revenue 2022: $50,752Expenses 2022: $66,892Net Income 2022: -$16,1402022Revenue 2023: $40,183Expenses 2023: $74,555Net Income 2023: -$34,3722023Revenue 2024: $95,740Expenses 2024: $108,988Net Income 2024: -$13,2482024

Highlighted filing

2020

Revenue$284,237
Expenses$257,759
Net Income$26,478
Filing Detail Status

This 2020 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2020 to Dec 31, 2020
Mission and Program Overview

Mission

To treat and prevent retinopathy of prematurity in eastern europe, black sea countries, and russian federation and where half their babies go blind from rop. To reduce blindness from retinopathy of prematurity(rop) in target countries.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings